Editorial: nocebo effect and switching to biosimilars

Aliment Pharmacol Ther. 2018 Mar;47(6):850-851. doi: 10.1111/apt.14509.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Humans
  • Inflammatory Bowel Diseases*
  • Infliximab
  • Nocebo Effect
  • Prospective Studies

Substances

  • Biosimilar Pharmaceuticals
  • Infliximab